HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Potential anticancer agents XXXI. N-demethylation of fagaronine.

Abstract
Fusion of fagaronine (1) afforded N-demethyl fagaronine (2) and two minor desmethyl products. Through examination of spectral properties and derivatization, the structures were deduced to be 3, a tetramethoxy derivative, and 5, a derivative bearing a hydroxy (rather than a methoxy) group at position-8. Acetylation of 2 afforded a monoacetate derivative (4), and similarly, a diacetate (6) was produced from 5. Compounds 2-6 were substantially less cytotoxic than 1, as judged by KB or P-388 cell culture assays, supporting the functional importance of the quaternary nitrogen atom. The results obtained to date for fagaronine in tumor panel-testing are also presented, and the marginal cytotoxic activity demonstrated by compounds 5 and 6 against cultured P-388 cells is discussed in terms of mechanisms of action of the parent compound.
AuthorsM Arisawa, J M Pezzuto, C Bevelle, G A Cordell
JournalJournal of natural products (J Nat Prod) 1984 May-Jun Vol. 47 Issue 3 Pg. 453-8 ISSN: 0163-3864 [Print] United States
PMID6481359 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Alkaloids
  • Antineoplastic Agents, Phytogenic
  • Benzophenanthridines
  • Phenanthridines
  • fagaronine
Topics
  • Alkaloids
  • Animals
  • Antineoplastic Agents, Phytogenic (chemical synthesis)
  • Benzophenanthridines
  • Chemical Phenomena
  • Chemistry
  • Dealkylation
  • Leukemia P388 (drug therapy)
  • Magnetic Resonance Spectroscopy
  • Mice
  • Phenanthridines

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: